Abdominal obesity and metabolic syndrome
- PMID: 17167477
- DOI: 10.1038/nature05488
Abdominal obesity and metabolic syndrome
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Similar articles
-
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20. Arterioscler Thromb Vasc Biol. 2008. PMID: 18356555 Review.
-
Abdominal adiposity and cardiometabolic risk: do we have all the answers?Am J Med. 2007 Sep;120(9 Suppl 1):S10-6; discussion S16-7. doi: 10.1016/j.amjmed.2007.06.006. Am J Med. 2007. PMID: 17720354 Review.
-
Obesity and the metabolic syndrome.Minerva Endocrinol. 2004 Jun;29(2):47-54. Minerva Endocrinol. 2004. PMID: 15257255 Review.
-
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343. Expert Rev Cardiovasc Ther. 2008. PMID: 18327995 Review.
-
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.Semin Vasc Med. 2002 Feb;2(1):45-57. doi: 10.1055/s-2002-23095. Semin Vasc Med. 2002. PMID: 16222595 Review.
Cited by
-
Glucosinolate extract from radish (Raphanus sativus L.) seed attenuates high-fat diet-induced obesity: insights into gut microbiota and fecal metabolites.Front Nutr. 2024 Aug 8;11:1442535. doi: 10.3389/fnut.2024.1442535. eCollection 2024. Front Nutr. 2024. PMID: 39176030 Free PMC article.
-
Quercetin activates energy expenditure to combat metabolic syndrome through modulating gut microbiota-bile acids crosstalk in mice.Gut Microbes. 2024 Jan-Dec;16(1):2390136. doi: 10.1080/19490976.2024.2390136. Epub 2024 Aug 20. Gut Microbes. 2024. PMID: 39163273 Free PMC article.
-
The association between anthropometric indices and ischemic heart disease: a large-scale cross-sectional study on the Iranian population.Sci Rep. 2024 Aug 15;14(1):18950. doi: 10.1038/s41598-024-54148-z. Sci Rep. 2024. PMID: 39147775 Free PMC article.
-
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.Front Pharmacol. 2024 Jul 31;15:1430109. doi: 10.3389/fphar.2024.1430109. eCollection 2024. Front Pharmacol. 2024. PMID: 39144627 Free PMC article.
-
Association between waist circumference and chronic pain: insights from observational study and two-sample Mendelian randomization.Front Nutr. 2024 Jul 26;11:1415208. doi: 10.3389/fnut.2024.1415208. eCollection 2024. Front Nutr. 2024. PMID: 39131735 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical